Skip to content
Trial Agents

PROFIL Institut fuer Stoffwechselforschung

PROFIL Institut fuer Stoffwechselforschung is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
19recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A study to Assess the Effect of Vonafexor on Kidney Function in Subjects With Impaired Renal Function and Suspected MASH

Sponsor ENYO Pharma

Start (EU)
Latest update
Estimated end
Not reported

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly s.c. Administered GL0034 in Adults with Type 2 Diabetes Mellitus Inadequately controlled on Metformin Or Diet and Exercise

Sponsor Sun Pharmaceutical Industries Limited

Start (EU)
Latest update
Estimated end
Not reported

A randomized, double-blind, placebo-controlled proof-of-concept parallel group clinical trial to investigate the efficacy, safety and tolerability of weekly subcutaneous (SC) dosing of CK-0045 in participants with overweight / obesity and Type 2 diabetes

Sponsor Cytoki Pharma ApS

Start (EU)
Latest update
Estimated end
Not reported

Questions about this trial experience

What services are recorded for PROFIL Institut fuer Stoffwechselforschung?

The 2026-10-09 snapshot links PROFIL Institut fuer Stoffwechselforschung to 5 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Laboratory services, Medical writing, among 19 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for PROFIL Institut fuer Stoffwechselforschung?

The most frequently recorded therapeutic areas are Cardiology, Hepatology, Metabolic Disorders. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to PROFIL Institut fuer Stoffwechselforschung conducted?

The linked trials record locations in 1 country, including Germany. These are trial locations, not confirmed office locations or countries where PROFIL Institut fuer Stoffwechselforschung delivered services.

What can this page tell me about PROFIL Institut fuer Stoffwechselforschung's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under PROFIL Institut fuer Stoffwechselforschung. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • PROFIL Institut fuer Stoffwechselforschung GmbH

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.